Cardlytics Inc (CDLX)

$15.29

+1.34

(+9.61%)▲

Market is closed - opens 7 PM, 28 Sep 2023

Insights on Cardlytics Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 64.33M → 143.33M (in $), with an average increase of 55.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 13.60M → -93.25M (in $), with an average decrease of 785.3% per quarter

  • Vs CMPR

    In the last 1 year, Cimpress N.v. has given 171.7% return, outperforming this stock by 126.7%

  • Vs IPG

    In the last 3 years, Cardlytics Inc has experienced a drawdown of -79.5%, however Interpublic Group Of Companies, Inc. resisted the overall trend and outperformed by 76.4%

Performance

  • $14.02
    $15.45
    $15.29
    downward going graph

    8.31%

    Downside

    Day's Volatility :9.26%

    Upside

    1.04%

    downward going graph
  • $2.57
    $19.57
    $15.29
    downward going graph

    83.19%

    Downside

    52 Weeks Volatility :86.87%

    Upside

    21.87%

    downward going graph

Returns

PeriodCardlytics IncSector (Communication Services)Index (Russel 2000)
3 Months
132.5%
0.9%
0.0%
6 Months
428.41%
15.5%
1.0%
1 Year
45.01%
35.4%
6.4%
3 Years
-79.72%
11.2%
19.9%

Highlights

Market Capitalization
649.6M
Book Value
$6.37
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-12.25
Wall Street Target Price
17.0
Profit Margin
-128.92%
Operating Margin TTM
-32.56%
Return On Assets TTM
-7.0%
Return On Equity TTM
-95.45%
Revenue TTM
296.2M
Revenue Per Share TTM
8.79
Quarterly Revenue Growth YOY
1.7000000000000002%
Gross Profit TTM
115.4M
EBITDA
-65.4M
Diluted Eps TTM
-12.25
Quarterly Earnings Growth YOY
-0.57
EPS Estimate Current Year
-0.31
EPS Estimate Next Year
-0.16
EPS Estimate Current Quarter
-0.35
EPS Estimate Next Quarter
-0.17

Analyst Recommendation

Buy
    60%Buy
    40%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Cardlytics Inc(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
1
1
Hold
4
5
5
Sell
00
5
5

Analyst Forecast

What analysts predicted

Upside of 11.18%

Current $15.29
Target $17.00

Company Financials

FY17Y/Y Change
Revenue
130.4M
↑ 15.55%
Net Income
-19.6M
↓ 74.05%
Net Profit Margin
-15.07%
↑ 52.02%
FY18Y/Y Change
Revenue
150.7M
↑ 15.59%
Net Income
-53.0M
↑ 170.06%
Net Profit Margin
-35.2%
↓ 20.13%
FY19Y/Y Change
Revenue
210.4M
↑ 39.65%
Net Income
-17.1M
↓ 67.68%
Net Profit Margin
-8.15%
↑ 27.05%
FY20Y/Y Change
Revenue
186.9M
↓ 11.19%
Net Income
-55.4M
↑ 223.27%
Net Profit Margin
-29.65%
↓ 21.5%
FY21Y/Y Change
Revenue
267.1M
↑ 42.93%
Net Income
-128.6M
↑ 131.97%
Net Profit Margin
-48.13%
↓ 18.48%
FY22Y/Y Change
Revenue
298.5M
↑ 11.76%
Net Income
-465.3M
↑ 261.89%
Net Profit Margin
-155.85%
↓ 107.72%
Q1 FY22Q/Q Change
Revenue
67.9M
↓ 24.57%
Net Income
33.0M
↓ 379.18%
Net Profit Margin
48.64%
↑ 61.78%
Q2 FY22Q/Q Change
Revenue
75.4M
↑ 11.01%
Net Income
-126.3M
↓ 482.26%
Net Profit Margin
-167.48%
↓ 216.12%
Q3 FY22Q/Q Change
Revenue
72.7M
↓ 3.58%
Net Income
6.3M
↓ 104.96%
Net Profit Margin
8.62%
↑ 176.1%
Q4 FY22Q/Q Change
Revenue
82.5M
↑ 13.47%
Net Income
-378.3M
↓ 6136.05%
Net Profit Margin
-458.5%
↓ 467.12%
Q1 FY23Q/Q Change
Revenue
64.3M
↓ 22.03%
Net Income
13.6M
↓ 103.6%
Net Profit Margin
21.15%
↑ 479.65%
Q2 FY23Q/Q Change
Revenue
143.3M
↑ 122.81%
Net Income
-93.3M
↓ 785.27%
Net Profit Margin
-65.06%
↓ 86.21%
FY17Y/Y Change
Total Assets
100.8M
↑ 16.0%
Total Liabilities
309.4M
↑ 1.89%
FY18Y/Y Change
Total Assets
153.8M
↑ 52.61%
Total Liabilities
101.8M
↓ 67.11%
FY19Y/Y Change
Total Assets
224.3M
↑ 45.88%
Total Liabilities
81.0M
↓ 20.38%
FY20Y/Y Change
Total Assets
422.5M
↑ 88.37%
Total Liabilities
265.3M
↑ 227.4%
FY21Y/Y Change
Total Assets
1.3B
↑ 199.1%
Total Liabilities
573.1M
↑ 115.98%
FY22Y/Y Change
Total Assets
691.2M
↓ 45.3%
Total Liabilities
479.6M
↓ 16.31%
Q1 FY22Q/Q Change
Total Assets
1.2B
↓ 2.58%
Total Liabilities
519.5M
↓ 9.35%
Q2 FY22Q/Q Change
Total Assets
1.1B
↓ 11.51%
Total Liabilities
525.4M
↑ 1.12%
Q3 FY22Q/Q Change
Total Assets
1.1B
↓ 2.13%
Total Liabilities
485.8M
↓ 7.53%
Q4 FY22Q/Q Change
Total Assets
691.2M
↓ 35.18%
Total Liabilities
479.6M
↓ 1.27%
Q1 FY23Q/Q Change
Total Assets
684.6M
↓ 0.96%
Total Liabilities
452.3M
↓ 5.7%
Q2 FY23Q/Q Change
Total Assets
608.9M
↓ 11.06%
Total Liabilities
372.8M
↓ 17.57%
FY17Y/Y Change
Operating Cash Flow
-22.1M
↓ 31.99%
Investing Cash Flow
-1.6M
↓ 35.28%
Financing Cash Flow
21.8M
↓ 29.37%
FY18Y/Y Change
Operating Cash Flow
-19.0M
↓ 14.06%
Investing Cash Flow
-7.3M
↑ 345.78%
Financing Cash Flow
65.2M
↑ 199.58%
FY19Y/Y Change
Operating Cash Flow
11.5M
↓ 160.32%
Investing Cash Flow
-11.0M
↑ 50.1%
Financing Cash Flow
44.2M
↓ 32.23%
FY20Y/Y Change
Operating Cash Flow
-7.6M
↓ 166.32%
Investing Cash Flow
-10.1M
↓ 8.19%
Financing Cash Flow
206.4M
↑ 367.26%
FY21Y/Y Change
Operating Cash Flow
-38.5M
↑ 407.02%
Investing Cash Flow
-506.7M
↑ 4908.35%
Financing Cash Flow
486.0M
↑ 135.43%
FY22Y/Y Change
Operating Cash Flow
-53.9M
↑ 39.93%
Investing Cash Flow
-15.8M
↓ 96.89%
Financing Cash Flow
-40.0M
↓ 108.23%
Q1 FY22Q/Q Change
Operating Cash Flow
-19.7M
↑ 3447.93%
Investing Cash Flow
-3.4M
↑ 0.0%
Financing Cash Flow
182.0K
↓ 19.11%
Q2 FY22Q/Q Change
Operating Cash Flow
-6.7M
↓ 66.09%
Investing Cash Flow
-4.3M
↑ 25.04%
Financing Cash Flow
-40.0M
↓ 22069.23%
Q3 FY22Q/Q Change
Operating Cash Flow
-14.4M
↑ 116.14%
Investing Cash Flow
-3.3M
↓ 22.6%
Financing Cash Flow
-6.0K
↓ 99.98%
Q4 FY22Q/Q Change
Operating Cash Flow
-13.1M
↓ 9.24%
Investing Cash Flow
-3.2M
↓ 4.57%
Financing Cash Flow
-179.0K
↑ 2883.33%
Q1 FY23Q/Q Change
Operating Cash Flow
-10.1M
↓ 23.18%
Investing Cash Flow
-2.8M
↓ 11.13%
Financing Cash Flow
30.0M
↓ 16849.16%

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardlytics Inc
Cardlytics Inc
0.65%
428.41%
45.01%
-79.72%
-43.68%
Ziff Davis Inc
Ziff Davis Inc
-2.56%
-14.55%
-5.69%
-48.24%
-48.24%
Integral Ad Science Holding Llc
Integral Ad Science Holding Llc
-14.65%
-15.64%
64.78%
-43.39%
-43.39%
Cimpress N.v.
Cimpress N.v.
10.9%
67.68%
171.67%
-6.71%
-49.51%
Omnicom Group Inc.
Omnicom Group Inc.
-8.68%
-17.01%
16.92%
-11.52%
-11.52%
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
-12.72%
-20.02%
11.64%
66.57%
24.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardlytics Inc
Cardlytics Inc
NA
NA
NA
-0.31
-0.95
-0.07
0.0
6.37
Ziff Davis Inc
Ziff Davis Inc
32.22
32.22
0.84
6.32
0.05
0.04
0.01
40.14
Integral Ad Science Holding Llc
Integral Ad Science Holding Llc
95.4
95.4
NA
0.08
0.03
0.01
0.0
5.62
Cimpress N.v.
Cimpress N.v.
NA
NA
-9.11
-7.82
0.0
0.03
0.0
-23.65
Omnicom Group Inc.
Omnicom Group Inc.
10.85
10.85
5.64
7.34
0.38
0.05
0.04
15.96
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
12.03
12.03
16.25
2.92
0.26
0.05
0.04
9.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardlytics Inc
Cardlytics Inc
Buy
$649.6M
-43.68%
NA
-128.92%
Ziff Davis Inc
Ziff Davis Inc
Buy
$3.0B
-48.24%
32.22
6.9%
Integral Ad Science Holding Llc
Integral Ad Science Holding Llc
Buy
$2.2B
-43.39%
95.4
5.26%
Cimpress N.v.
Cimpress N.v.
Buy
$1.9B
-49.51%
NA
-6.04%
Omnicom Group Inc.
Omnicom Group Inc.
Buy
$14.5B
-11.52%
10.85
9.66%
Interpublic Group Of Companies, Inc.
Interpublic Group Of Companies, Inc.
Buy
$11.1B
24.62%
12.03
10.06%

Institutional Holdings

  • BlackRock Inc

    7.57%

  • 683 Capital Management LLC

    5.43%

  • Vanguard Group Inc

    4.72%

  • Baillie Gifford & Co Limited.

    3.82%

  • KPS Global Asset Management UK Ltd

    3.23%

  • Marshall Wace Asset Management Ltd

    2.98%

Corporate Announcements

  • Cardlytics Inc Earnings

    Cardlytics Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. we partner with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. in turn, we have a secure view into where and when consumers are spending their money. we use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. at cardlytics, we are analysts, developers, and data scientists. we are marketers, account managers, and consultants to our clients. we are all focused on making sense of the data we see to make it informative and actionable for our partners. headquartered in atlanta, ga, with offices in new york city, london, san francisco, and chicago, our team rallies around a common desire to win and to help our clients win. we are focused on building a revolutionizing company, but we still care about each other

Organization
Cardlytics Inc
Employees
473
CEO
Mr. Andrew C. Christiansen
Industry
Technology Services

Discover More

FAQs